美国生物技术公司Vericel Corporation今日盘中股价大涨6%,报52.57美元/股,成交量较大。最新财报显示,该公司第三季度实现营收5791万美元,有望持续盈利。
分析人士指出,尽管暂无突发利好消息,但Vericel Corporation的强劲财报数据和机构投资者的看好评级或是推动其股价当日大涨的原因。该公司业绩持续向好,在医疗行业前景广阔,获得了资本市场较高认可。
截至目前,有7家机构对Vericel Corporation股票评级,其中100%给予"买入"评级,无持有和卖出评级。这表明外资和专业机构对公司的长期增长预期普遍积极向好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.